SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: ubernano, TomP1
Search This Board: 
Last Post: 2/24/2017 8:08:06 PM - Followers: 407 - Board type: Free - Posts Today: 1

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#13518  Sticky Note 2016 VALUE DRIVERS & MILESTONES (2nd-Half of 2016 Dr_Thorfin 08/01/16 01:50:30 PM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13812   Positive news and the SP goes down. Of course! radly 02/24/17 08:08:06 PM
#13810   Inovio Reports New Positive Clinical Data on Vaccine TomP1 02/23/17 08:20:49 AM
#13809   China - the future by ApolloBio ubernano 02/13/17 01:56:00 PM
#13808  Restored This INO - ApolloBio deal could be what ubernano 02/13/17 12:41:22 PM
#13807   ApolloBio Corporation ubernano 02/13/17 09:18:21 AM
#13806   GANGBUSTERS! I'm raising my quite conservative $100 estimate for ubernano 02/13/17 09:06:00 AM
#13805   This is also 15 million for a very desarcmo 02/13/17 08:57:12 AM
#13804  Restored $15 million. Can somebody please tell MiamiGent to 7Bullet7 02/13/17 07:49:46 AM
#13803   Excellent! When is the FDA to lift this pre-clinical TomP1 02/13/17 07:07:30 AM
#13802   Inovio and ApolloBio to Collaborate on Development and lasers 02/13/17 06:54:31 AM
#13801   INO takes money and delivers health. ubernano 02/03/17 10:09:36 AM
#13800   All that taxpayer money and INO has nothing MiamiGent 02/02/17 10:43:29 PM
#13799   Dr. Kim says Inovio has received a total ubernano 02/02/17 12:52:47 PM
#13798   INO, Sanofi & tiny GOVX: Zika science leaders.Link remind2 02/02/17 10:03:08 AM
#13797   INO is not for everybody. ubernano 01/26/17 10:42:39 AM
#13795  Restored I believe in making America great. ubernano 01/26/17 09:52:19 AM
#13794   I would never play a stock that is MiamiGent 01/26/17 09:52:14 AM
#13793  Restored I believe in making America great. ubernano 01/26/17 09:50:52 AM
#13792   I bought INO at $1 and it is ubernano 01/26/17 09:48:53 AM
#13791   Puleeze- the Defense Dept. gives out research money MiamiGent 01/26/17 09:10:39 AM
#13790   DARPA sees it completely different. If only they TomP1 01/26/17 01:34:38 AM
#13789   How Risky Is Inovio Pharmaceuticals, Inc.? MiamiGent 01/25/17 11:06:57 PM
#13788   Inovio (INO) has had numerous name changes, about MiamiGent 01/25/17 08:45:31 PM
#13787   For INO, focus on recent years when Dr avav1001 01/24/17 05:41:44 PM
#13786   TIME TO PUT ON THE WATCH LIST? – ubernano 01/24/17 02:50:43 PM
#13785   INO has me in its grasp! ubernano 01/24/17 02:02:28 PM
#13784  Restored Time's up. MiamiGent 01/24/17 12:43:46 PM
#13783   Where is the facts (beef)? ubernano 01/24/17 12:23:02 PM
#13782   All the board seats he wiggled into doesn't MiamiGent 01/24/17 12:16:41 PM
#13781   Got it, I think: ubernano 01/24/17 09:41:10 AM
#13780   Chances for the 1st 2 or 3 decades MiamiGent 01/23/17 05:28:11 PM
#13779   Chances for the 1st 2 or 3 decades avav1001 01/23/17 04:53:40 PM
#13778   You can find that info in my INO thread. MiamiGent 01/23/17 04:25:13 PM
#13777   a crooked penny stock operator What's his name?? ubernano 01/23/17 04:17:14 PM
#13776   Penny?? It's $ s the last I checked. ubernano 01/23/17 04:11:09 PM
#13775   33 years of chances is enough. MiamiGent 01/23/17 04:09:39 PM
#13774   Yes, electroporation has been around for decades, but avav1001 01/23/17 04:04:35 PM
#13773   INO Sorry to have to tell you that MiamiGent 01/22/17 02:45:47 PM
#13772   Effectiveness of DNA vaccines has been exponentially improved avav1001 01/22/17 01:41:40 PM
#13771   The Inovio story is devolving into comedy. I ubernano 01/12/17 12:44:29 PM
#13770   INO So now the hope here is effectiveness MiamiGent 01/12/17 10:16:20 AM
#13769   More Innovation, Less Regulation: 2 Biotech Stocks That ubernano 01/11/17 01:06:30 PM
#13768   Great post! Buy under 5 Fibanotch 01/10/17 09:32:26 AM
#13767   Thanks MG! ubernano 12/28/16 10:01:39 AM
#13766   A great company? It hasn't produced anything during MiamiGent 12/27/16 07:58:00 PM
#13765   This news brings $20+ as we approach mosquito biotechnician 12/27/16 01:41:11 PM
#13761   Iovio is a great company and as a ubernano 12/26/16 01:10:39 PM
#13760   Approval is not a given but they are INTL 12/26/16 11:27:39 AM
#13759   MedImmune? AstraZeneca? DARPA? Department of Defense? TomP1 12/26/16 04:51:25 AM
#13758   Sorry where do you see the victory claim??? TomP1 12/26/16 04:50:32 AM